Alnylam Pharmaceuticals Inc
ALNY400.590USD
-0.100-0.02%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
52.79BMarket Cap
1233.61P/E TTM
Alnylam Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
2.25B
22.97%
EPS(YoY)
-2.18
38.18%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 2.25B, with a year-on-year change of 22.97%.
What is the Earnings Per Share (EPS) of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.179, with a year-on-year change of 38.18%.
What is the net income of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its net income was -278.16M, with a year-on-year change of 36.82%.
What is the net margin of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was -12.37%, with a year-on-year change of 48.62%.
What is the gross margin of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 85.62%, with a year-on-year change of 3.13%.
What is the debt-to-asset ratio of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 58.30%, with a year-on-year change of 118.74%.
What is the Return on Equity (ROE) of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.
What is the Return on Assets (ROA) of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -6.89%, with a year-on-year change of 42.25%.
What is the operating profit of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its operating profit was -176.88M, with a year-on-year change of 37.31%.
What are the current assets of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its current assets were 3.30B, with a year-on-year change of 10.48%.
What are the total assets of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its total assets of Alnylam Pharmaceuticals Inc were 4.24B, with a year-on-year change of 10.71%.
What are the total liabilities of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Alnylam Pharmaceuticals Inc were 4.17B, with a year-on-year change of 3.02%.
What is the total equity of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its total equity of Alnylam Pharmaceuticals Inc was 67.09M, with a year-on-year change of 130.41%.
What is the net operating income of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Alnylam Pharmaceuticals Inc was -278.16M, with a year-on-year change of 36.82%.
What is the net investment of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its net investment of Alnylam Pharmaceuticals Inc was -116.84M, with a year-on-year change of 65.26%.
What is the net financing of Alnylam Pharmaceuticals Inc?
According to Alnylam Pharmaceuticals Inc's FY2024 earnings report, its net financing of Alnylam Pharmaceuticals Inc was 294.16M, with a year-on-year change of 70.89%.
